FDA Inspection 1000188 — Matrix Pharmacorp Private Limited

Matrix Pharmacorp Private Limited — FEI 3003227156

The FDA completed an inspection of Matrix Pharmacorp Private Limited on Dec 30, 2016 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 30, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hyderabad (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.